CADE (NYSE: CADE) holder plans Rule 144 sale of 51,076 shares
Rhea-AI Filing Summary
James D. Rollins III has filed a notice of intent to sell 51,076 common shares of CADE under Rule 144. The planned sale has an aggregate market value of 2,209,064.28, with an approximate sale date of 12/16/2025 on the NYSE through Fidelity Brokerage Services LLC. Shares outstanding were 183,527,575 common shares.
The shares to be sold were acquired as restricted stock vesting compensation from the issuer on three dates in 2025: 36,373 shares on 03/31/2025, 14,609 shares on 05/15/2025, and 94 shares on 12/08/2025, all paid as compensation. During the past three months, Rollins sold 23,145 common shares on 12/15/2025 for gross proceeds of 1,011,252.56.
Positive
- None.
Negative
- None.
FAQ
What does the CADE Form 144 filing disclose?
The filing shows that James D. Rollins III intends to sell 51,076 common shares of CADE under Rule 144, detailing the planned sale terms and how the shares were acquired.
How many CADE shares are planned to be sold and what is their value?
The notice covers a planned sale of 51,076 common shares with an aggregate market value of 2,209,064.28 as stated in the filing.
When and where will the CADE shares be sold?
The approximate sale date listed is 12/16/2025, and the shares are to be sold on the NYSE through Fidelity Brokerage Services LLC.
How did the seller acquire the CADE shares covered by this notice?
The shares were acquired as restricted stock vesting from the issuer, treated as compensation, on three dates: 03/31/2025 (36,373 shares), 05/15/2025 (14,609 shares), and 12/08/2025 (94 shares).
Has James D. Rollins III recently sold other CADE shares?
Yes. During the past three months, he sold 23,145 common shares on 12/15/2025 for 1,011,252.56 in gross proceeds.
How many CADE shares are outstanding compared with this planned sale?
The filing states there are 183,527,575 common shares outstanding, which provides context for the planned sale of 51,076 shares.